Evidence map›Paper›PMID 39684501›Full record

SynthesisInternational journal of molecular sciences2024

Resveratrol and Female Fertility: A Systematic Review.

Alessandro Bertoldo, Damiano Pizzol, Dong Keon Yon, Maura Callegari, Valentina Gobbo, Pierluigi Cuccurese, Laurie Butler, Susanna Caminada, Justin Stebbing, Fiona Richardson and 2 more

Abstract readSystematic Review
In one paragraph

Synthesis in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Paternal and/or Maternal Blackberry (Antioxidants (Basel, Switzerland) · 2025
    Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alessandro BertoldoU.O.S.D. of Assisted Reproductive Technologies "G. Beltrame", Ospedale di Oderzo, ULSS2, 31046 Treviso, Italy.
Damiano PizzolHealth Unit, Eni, Maputo 1100, Mozambique.ORCID 0000-0003-4122-0774
Dong Keon YonCenter for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul 02447, Republic of Korea.ORCID 0000-0003-1628-9948
Maura CallegariU.O.S.D. of Assisted Reproductive Technologies "G. Beltrame", Ospedale di Oderzo, ULSS2, 31046 Treviso, Italy.
Valentina GobboU.O.S.D. of Assisted Reproductive Technologies "G. Beltrame", Ospedale di Oderzo, ULSS2, 31046 Treviso, Italy.
Pierluigi CuccureseDepartment of Obstetrics and Gynecology, Ospedale di Oderzo, ULSS2, 31046 Treviso, Italy.
Laurie ButlerFaculty of Science and Engineering, Anglia Ruskin University, Cambridge CB1 1PT, UK.
Susanna CaminadaHealth Unit, Eni, 00144 Rome, Italy.
Justin StebbingDepartment of Life Sciences, Anglia Ruskin University, Cambridge CB1 1PT, UK.
Fiona RichardsonThe Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn PE30 4ET, UK.
Julia GawronskaCentre for Health, Performance and Wellbeing, Anglia Ruskin University, Cambridge CB1 1PT, UK.
Lee SmithCentre for Health, Performance and Wellbeing, Anglia Ruskin University, Cambridge CB1 1PT, UK.ORCID 0000-0002-5340-9833

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol is a natural polyphenolic compound that may have multiple influences on human health, including antiaging, anti-inflammatory, anti-neoplastic, antioxidant, insulin-sensitizing, cardioprotective and vasodilating activities. Growing evidence also suggests a potential positive effect of resveratrol on female fertility. The aim of the present study was to collate and appraise the scientific literature on the relationship between resveratrol and female fertility. We systematically searched Medline, PubMed, Web of Science and Embase from the databases' inception (1951, 1951, 1947 and 1900, respectively) until 9th May 2024. All in vivo or in vitro retrospective or prospective studies reporting the effects of resveratrol interventions on women's fertility were included. We ultimately incorporated twenty-four studies into a systematic review with a narrative summary of the results; of those studies, nine were performed on women seeking natural or assisted fertility, and fifteen were in vitro studies performed on human cells and tissues in different stages of the reproductive cascade. The current literature, though limited, suggests that resveratrol may play a role in female infertility. Specifically, it may significantly and positively impact reproductive outcomes, owing to its potential therapeutic effects improving ovarian function. Further studies are now needed to better understand resveratrol's effects and define the optimal dosage and periods of intake to maximize beneficial effects, as well as to prevent adverse outcomes on implantation, subsequent pregnancy and the fetus.

Indexed as

FertilityInfertility, FemaleResveratrolAntioxidantsFemaleHumansPregnancyAntioxidantsResveratrol3,5,4-trihydroxystilbenefemale fertilityfemale infertilityresveratrol

Identifiers

PMID39684501
PMCPMC11641680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.